Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$10.65 - $14.29 $1.79 Million - $2.4 Million
-167,951 Reduced 99.91%
149 $2,000
Q3 2018

Feb 11, 2021

BUY
$17.77 - $22.9 $2.96 Million - $3.81 Million
166,419 Added 9900.0%
168,100 $3.65 Million
Q3 2018

Nov 14, 2018

BUY
$17.77 - $22.9 $28,787 - $37,098
1,620 Added 2655.74%
1,681 $155,000
Q2 2018

Aug 14, 2018

BUY
$17.33 - $23.4 $1,057 - $1,427
61 New
61 $3,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.86B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.